GSK Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK Pharma Quarterly Results    (GLXO)

Here are the latest quarterly results of GSK Pharma. For more details, see the GSK Pharma financial fact sheet and GSK Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

GSK Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-17
3
Mar-18
3
Jun-18
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
8-Qtr Chart
Click to enlarge
Net Sales Rs m7,0397,4867,3578,1638,2547,5127,8808,821 
Other income Rs m120183178148164525305156 
Turnover Rs m7,1597,6697,5348,3118,4188,0378,1868,977 
Expenses Rs m5,6215,9385,9536,5126,8805,8766,2256,879 
Gross profit Rs m1,4181,5491,3211,5341,6551,6051,6555,954 
Depreciation Rs m13494114115120137191227 
Interest Rs m02221199 
Profit before tax Rs m1,4041,6361,3831,5651,6981,9921,7605,874 
Tax Rs m507581497557568761626846 
Profit after tax Rs m8971,0568861,0081,1301,2301,1355,028 
Gross profit margin %20.120.718.018.820.021.421.067.5 
Effective tax rate %36.135.535.935.633.538.235.514.4 
Net profit margin %12.714.112.012.313.716.414.457.0 
Diluted EPS Rs 5.3 6.2 5.2 5.9 6.7 7.3 6.7 29.7  
Diluted EPS (TTM) Rs 21.2 20.8 24.4 22.7 24.1 25.1 26.6 50.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: GSK Pharma 2QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   PIRAMAL ENTERPRISES  NOVARTIS  FRESENIUS KABI ONCO.  STRIDES PHARMA SCIENCE  NATCO PHARMA  

Compare GSK PHARMA With:   PIRAMAL ENTERPRISES  NOVARTIS  FRESENIUS KABI ONCO.  STRIDES PHARMA SCIENCE  NATCO PHARMA  

Compare GSK PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 169 Points Higher; Auto and Metal Stocks Witness Buying(Closing)

Indian share markets continued to trade on a positive note during closing hours and ended their session in the green.

Views on news

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, GSK PHARMA has posted a net profit of Rs 5 bn (up 398.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020 (Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks (Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets? (The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Dec 12, 2019 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

GSK PHARMA - TEVA PHARMA COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS